Newsletter | November 9, 2021

11.09.21 -- The Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

Industry Insights
The Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

There are three major challenges inherent to commercializing a biotherapeutic: technical challenges, regulatory challenges, and market supply challenges. Working with a partner that can provide a one-stop shop for bioconjugate development and manufacturing can help prevent any missteps that could threaten a biopharmaceutical company’s ability to deliver life-saving drugs to patients who need them.

How Does Media Selection Impact Performance Testing Of Poorly Soluble Drugs?

Lonza Biologics recently presented a webinar on the design of dissolution media to support biopredictive dissolution testing, which enables the development of bioavailability-enhancing formulations for poorly soluble drugs.

Fundamentals Of Size Exclusion Chromatography

Size exclusion chromatography (SEC), also known as gel filtration, is the mildest of all chromatography techniques. SEC separates molecules by their differences in size as they pass through a resin packed in a column. You can use SEC for both preparative and analytical studies of your protein. But how do you know which parameters will give you the best resolution of your protein mixture?

Integrated Lab Operations For Efficiency And Compliance

A research-based biopharmaceutical company had recently transitioned from paper-based experimental documentation towards increasingly electronic-based systems. Through the integration of their lab informatics systems the customer has observed improvements in both compliance and workflow efficiency.

IND Submissions In China – What Is Different To Other Territories?

The number of regulatory submissions in China is increasing. This webinar provides an overview of Chinese regulations with a specific focus on data and requirements for clinical trial applications.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.